z-logo
open-access-imgOpen Access
Omalizumab maintains a longer remission period than predicted: An observational study
Author(s) -
Belma TÜRSEN,
Habibullah Aktaş
Publication year - 2021
Publication title -
mersin üniversitesi sağlık bilimleri dergisi/mersin üniversitesi sağlık bilimleri dergisi
Language(s) - Turkish
Resource type - Journals
eISSN - 1308-0830
pISSN - 1308-0822
DOI - 10.26559/mersinsbd.1007723
Subject(s) - omalizumab , medicine , observational study , pediatrics , gynecology , immunoglobulin e , antibody , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here